European Immunization Week (EIW) is marked across Europe every year in the final week of April, to raise awareness of the importance of immunisation for the general health and well-being of the European and wider population.
The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) convened on 6 and 7 December in Amsterdam the first meeting of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB) of the Vaccine Monitoring Platform (VMP).
Globally, as of 9 August, 19 cases of polio due to wild poliovirus type 1 (WPV1) and 223 cases due to circulating vaccine derived poliovirus (cVDPV) have been reported this year. In 2022, the cVDPV cases have been reported in 15 countries, with 93% of the cases attributed to cVDPV type 2 (cVDPV2).
A new e-learning course aimed at understanding and addressing online vaccination misinformation is now available in the ECDC Virtual Academy. It was designed to support public health practitioners and risk communicators in fighting the spread of vaccination misinformation on social media and other digital platforms.
European Immunization Week (EIW) is marked across the European Region every April. It aims to raise awareness of the importance of immunisation for people’s health and well-being. ECDC supports the European Immunization Week campaign lead by WHO/Europe by providing scientific evidence on immunisation.
In order to improve the skills of European health professionals working in healthcare and public health in addressing the doubts and concerns of patients regarding vaccination, ECDC is convening an expert consultation meeting during 11-12 April 2019.
Increased rates of migration to and within the European Union and European Economic Area (EU/EEA) in recent years has made the development of migration policy, including health policy, a priority for the region.